UNSPSC 51284610: Ertapenem sodium

This classification denotes a beta-lactam antibiotic with the molecular formula C22H23N3O7S.H+.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2T90KE67L0, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-(((3-carboxyphenyl)amino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, disodium salt, (4r-(3(3s*,5s*),4alpha,5beta,6beta(r*)))- but more generally known as ertapenem sodium, which bears US NIH Compound Identifier 150611.

UNSPSC 51284610 Ertapenem sodium is a Commodity code for a specific injectable antibiotic product. State and local procurement activity under this code is sparse; the two most recent opportunities tagged to it involve unrelated pharmaceutical products — one an Illinois Department of Public Health piggyback award for oral antibiotics (Doxycycline and Ciprofloxacin) through the MMCAP Infuse cooperative purchasing vehicle, and another a Seminole County, Florida IFB for Naloxone and drug deactivation systems. Neither solicitation actually addresses ertapenem sodium. The code shows little concrete recent activity aligned with its stated scope, suggesting either minimal current demand from state and local buyers for this specific antibiotic or a mismatch between how opportunities are being tagged in procurement systems and the actual products being purchased.

Without recent opportunities genuinely soliciting ertapenem sodium, characterizing the issuing-body mix, geographic concentration, or representative buys under this code is not supported by the source. Firms evaluating activity under UNSPSC 51284610 should verify whether state and local health departments, prison systems, long-term care facilities, or other institutions are procuring this product through direct buys, group purchasing agreements, or cooperative-purchasing frameworks that may not be reflected in publicly posted RFPs or ITBs.